phenobarbital and orlistat

phenobarbital has been researched along with orlistat in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hafkamp, AM; Nelisse-Haak, R; Oude Elferink, RP; Sinaasappel, M; Verkade, HJ1

Reviews

1 review(s) available for phenobarbital and orlistat

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for phenobarbital and orlistat

ArticleYear
Orlistat treatment of unconjugated hyperbilirubinemia in Crigler-Najjar disease: a randomized controlled trial.
    Pediatric research, 2007, Volume: 62, Issue:6

    Topics: Adolescent; Adult; Anti-Obesity Agents; Bilirubin; Child; Combined Modality Therapy; Crigler-Najjar Syndrome; Cross-Over Studies; Dietary Fats; Double-Blind Method; Drug Therapy, Combination; Eating; Feces; Female; Humans; Lactones; Lipid Metabolism; Male; Middle Aged; Orlistat; Patient Compliance; Phenobarbital; Phototherapy; Treatment Outcome

2007

Other Studies

2 other study(ies) available for phenobarbital and orlistat

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011